<!DOCTYPE html>
<html lang="it">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Schema Ictus Ischemico - Fronte-Retro</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Arial', sans-serif;
            font-size: 6px;
            line-height: 1.1;
            background: white;
            color: #000;
        }
        
        .card-side {
            width: 6.5cm;
            height: 12.5cm;
            padding: 2mm;
            page-break-after: always;
            border: 1px solid #000;
            overflow: hidden;
        }
        
        .header {
            background: #d32f2f;
            color: white;
            text-align: center;
            font-weight: bold;
            font-size: 7px;
            padding: 1mm;
            margin-bottom: 1mm;
        }
        
        .section {
            margin-bottom: 1.2mm;
            border: 0.5px solid #333;
            padding: 0.8mm;
        }
        
        .section-title {
            background: #1976d2;
            color: white;
            font-weight: bold;
            font-size: 6px;
            padding: 0.5mm;
            margin: -0.8mm -0.8mm 1mm -0.8mm;
            text-align: center;
        }
        
        .urgent {
            background: #ff5722;
        }
        
        .success {
            background: #388e3c;
        }
        
        .warning {
            background: #f57c00;
        }
        
        .time-critical {
            color: #d32f2f;
            font-weight: bold;
        }
        
        .flowchart {
            background: #f3e5f5;
            border-left: 3px solid #9c27b0;
            padding: 1mm;
            margin: 0.5mm 0;
            font-size: 5px;
        }
        
        .criteria-box {
            background: #e8f5e8;
            border: 1px solid #4caf50;
            padding: 1mm;
            margin: 0.5mm 0;
            font-size: 5px;
        }
        
        ul {
            list-style: none;
            padding-left: 2mm;
        }
        
        li::before {
            content: "‚Ä¢ ";
            color: #1976d2;
            font-weight: bold;
        }
        
        .contraindication::before {
            content: "‚úó ";
            color: #d32f2f;
        }
        
        .indication::before {
            content: "‚úì ";
            color: #388e3c;
        }
        
        .small-text {
            font-size: 5px;
        }
        
        .bold {
            font-weight: bold;
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 5px;
            margin: 0.5mm 0;
        }
        
        td, th {
            border: 0.5px solid #333;
            padding: 0.5mm;
            text-align: left;
        }
        
        th {
            background: #e3f2fd;
            font-weight: bold;
        }
        
        .dosage {
            background: #fff3e0;
            padding: 0.5mm;
            font-weight: bold;
            border-left: 2px solid #ff9800;
            margin: 0.5mm 0;
            font-size: 5px;
        }
        
        .rule-of-six {
            background: #e1f5fe;
            border: 1px solid #0288d1;
            padding: 1mm;
            margin: 0.5mm 0;
            font-weight: bold;
            font-size: 5px;
        }
        
        @media print {
            .card-side {
                page-break-after: always;
            }
        }
    </style>
</head>
<body>
    <!-- FRONTE -->
    <div class="card-side">
        <div class="header">ICTUS ISCHEMICO - VALUTAZIONE RAPIDA</div>
        <div class="small-text" style="text-align: center; margin-bottom: 1mm; font-weight: bold; color: #d32f2f;">
            üìû mRS, ora di esordio, clinica, terapia domiciliare
        </div>
        
        <!-- VALUTAZIONE INIZIALE -->
        <div class="section">
            <div class="section-title urgent">üö® VALUTAZIONE IMMEDIATA</div>
            <div class="flowchart">
                <strong>1. Clinica:</strong> Ora esordio, NIHSS<br>
                <strong>2. Vitali:</strong> PA, glicemia, temperatura<br>
                <strong>3. Urgente:</strong> ECG, farmaci, prelievi<br>
                <strong>4. Imaging:</strong> TC ¬± Angio/Perfusione
            </div>
        </div>

        <!-- IMAGING E DECISIONI -->
        <div class="section">
            <div class="section-title">üîç FLUSSO DECISIONALE</div>
            <div class="flowchart">
                <strong>TC con EMORRAGIA ‚Üí NO trombolisi</strong><br>
                <strong>TC senza emorragia ‚Üí Analizza vaso:</strong><br>
                ‚Ä¢ <strong>LVO:</strong> ICA-T, M1, Basilare<br>
                ‚Ä¢ <strong>MeVO:</strong> M2/M3, A2/A3, P2/P3<br>
                ‚Ä¢ <strong>Piccoli vasi:</strong> terapia medica<br>
                <strong>BASILARE (BAO):</strong> IVT+EVT entro 24h
            </div>
        </div>

        <!-- TROMBOLISI -->
        <div class="section">
            <div class="section-title success">üíâ TROMBOLISI EV</div>
            <div class="criteria-box">
                <strong>CANDIDATI se:</strong><br>
                ‚Ä¢ Tempo &lt;4,5h o mismatch imaging<br>
                ‚Ä¢ PA &lt;185/110, glicemia 50-400<br>
                ‚Ä¢ INR &lt;1,7, PLT &gt;100k, no DOAC recenti<br>
                ‚Ä¢ Assenza controindicazioni
            </div>
            <div class="small-text">
                <strong>WAKE-UP:</strong> DWI+/FLAIR-<br>
                <strong>EXTEND:</strong> core &lt;70ml, penombra &gt;10ml, ratio &gt;1,2
            </div>
        </div>

        <!-- TROMBECTOMIA -->
        <div class="section">
            <div class="section-title success">üîß TROMBECTOMIA</div>
            <div class="rule-of-six">
                <strong>INDICAZIONI:</strong><br>
                ‚Ä¢ Tempo &lt;6h<br>
                ‚Ä¢ NIHSS ‚â•6<br>
                ‚Ä¢ mRS ‚â§2<br>
                <strong>BASILARE:</strong> NIHSS ‚â•10, finestra 24h
            </div>
            <div class="criteria-box">
                <strong>FINESTRA ESTESA (6-24h):</strong><br>
                <strong>DAWN:</strong> &lt;80aa: NIHSS‚â•10+core&lt;31ml<br>
                &lt;80aa: NIHSS‚â•20+core 31-59ml<br>
                &gt;80aa: NIHSS‚â•10+core&lt;21ml<br>
                <strong>DEFUSE-3:</strong> 6-16h, core&lt;70ml, mismatch‚â•15ml, ratio‚â•1,8
            </div>
        </div>

        <!-- COMPLICANZE TROMBOLISI -->
        <div class="section">
            <div class="section-title urgent">‚ö†Ô∏è COMPLICANZE TROMBOLISI</div>
            <div class="small-text">
                <strong>Emorragiche (6-7%):</strong>
                <ul>
                    <li>ICH sintomatica: stop IVT + TC</li>
                    <li>Se NIHSS +4: stop IVT + imaging</li>
                    <li>Emorragie extracraniche maggiori</li>
                </ul>
                <strong>Altre:</strong>
                <ul>
                    <li>Angioedema orolinguale (ACE-i)</li>
                    <li>Reazioni allergiche</li>
                    <li>Riocclusione (18%)</li>
                </ul>
                <strong>Gestione ICH:</strong> PCC-4F, neurochirurgia
            </div>
        </div>

        <!-- MONITORAGGIO POST-IVT -->
        <div class="section">
            <div class="section-title">üìä MONITORAGGIO POST-IVT</div>
            <div class="small-text">
                <strong>PA:</strong> &lt;180/105 x 24h (ogni 15min x 2h)<br>
                <strong>NIHSS:</strong> ogni 15min x 1h, poi 30min x 5h<br>
                <strong>Lab:</strong> emocromo + coag a 6-24h<br>
                <strong>TC controllo:</strong> 22-36h<br>
                <strong>ASA:</strong> dopo 24h + TC negativa
            </div>
        </div>
    </div>

    <!-- RETRO -->
    <div class="card-side">
        <div class="header">ICTUS ISCHEMICO - DETTAGLI PRATICI</div>

        <!-- DOSAGGI -->
        <div class="section">
            <div class="section-title success">üíä DOSAGGI FARMACI</div>
            <div class="dosage">
                <strong>TENECTEPLASE (preferita):</strong><br>
                0,25 mg/kg bolo (max 25mg)
            </div>
            <table>
                <tr><th colspan="2">Tenecteplase per peso</th></tr>
                <tr><td>&lt;60 kg</td><td>3ml (15mg)</td></tr>
                <tr><td>60-69 kg</td><td>3,5ml (17,5mg)</td></tr>
                <tr><td>70-79 kg</td><td>4ml (20mg)</td></tr>
                <tr><td>80-89 kg</td><td>4,5ml (22,5mg)</td></tr>
                <tr><td>‚â•90 kg</td><td>5ml (25mg)</td></tr>
            </table>
            <div class="dosage">
                <strong>ALTEPLASE:</strong><br>
                0,9 mg/kg (max 90mg)<br>
                10% bolo 2min + 90% in 60min
            </div>
        </div>

        <!-- CONTROINDICAZIONI -->
        <div class="section">
            <div class="section-title urgent">‚ö†Ô∏è CONTROINDICAZIONI</div>
            <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 1mm; font-size: 4.5px;">
                <div>
                    <strong>Cerebrali/Strutturali:</strong>
                    <ul>
                        <li class="contraindication">ICH/ESA (anche sospetta)</li>
                        <li class="contraindication">Neoplasia intra-assiale</li>
                        <li class="contraindication">MAV/aneurisma non trattati</li>
                    </ul>
                    <strong>Eventi recenti:</strong>
                    <ul>
                        <li class="contraindication">Stroke/trauma/chir. intracr. &lt;3m<br>&nbsp;&nbsp;&nbsp;(valutare caso per caso)</li>
                        <li class="contraindication">Chirurgia maggiore &lt;14gg</li>
                    </ul>
                </div>
                <div>
                    <strong>Coagulopatie:</strong>
                    <ul>
                        <li class="contraindication">INR &gt;1,7, PLT &lt;100k</li>
                        <li class="contraindication">DOAC &lt;48h, eparina+aPTT‚Üë</li>
                        <li class="contraindication">Endocardite, diss. aortica</li>
                    </ul>
                    <strong>Metaboliche/Altre:</strong>
                    <ul>
                        <li class="contraindication">Glicemia &lt;50 o &gt;400</li>
                        <li class="contraindication">PA &gt;185/110 refrattaria</li>
                        <li class="contraindication">STEMI &lt;7 giorni</li>
                    </ul>
                </div>
            </div>
        </div>

        <!-- ANTICOAGULANTI -->
        <div class="section">
            <div class="section-title warning">ü©∏ ANTICOAGULANTI E IVT</div>
            <div class="small-text" style="background: #fff9c4; padding: 0.5mm; margin-bottom: 0.5mm; font-weight: bold;">
                NB: EVT NON controindicata in anticoagulati/trombocitopenici
            </div>
            <table>
                <tr><th>Farmaco</th><th>IVT OK se:</th></tr>
                <tr><td><strong>Warfarin</strong></td><td>INR ‚â§1,7<br>Se &gt;1,7: casi selezionati dopo PCC-4F</td></tr>
                <tr><td><strong>Dabigatran</strong></td><td>aPTT norm + TT &lt;60s<br>o Hemoclot &lt;50ng/ml (6h)<br>o Idarucizumab 2√ó2,5g</td></tr>
                <tr><td><strong>LMWH</strong></td><td>Dose prof: sempre OK<br>Dose terap &lt;48h: aPTT &lt;40s e iXa &lt;0,1</td></tr>
                <tr><td><strong>Xaban</strong></td><td>&gt;24h con buona funz renale<br>o &lt;24h: iXa &lt;20ng/ml + antiXa &lt;0,5 + PT &lt;1,4</td></tr>
            </table>
            <div class="small-text" style="color: #d32f2f; font-weight: bold;">
                ‚Ä¢ NO Andexanet per IVT ‚Ä¢ Preferire EVT diretta se dubbi
            </div>
        </div>

        <!-- IPERGLICEMIA -->
        <div class="section">
            <div class="section-title warning">üçØ IPERGLICEMIA &gt;400mg/dL</div>
            <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 1mm; font-size: 4.5px;">
                <div>
                    <strong>1.</strong> Conferma con prelievo venoso<br>
                    <strong>2.</strong> Se confermata:<br>
                    &nbsp;&nbsp;&nbsp;<strong>Insulina regolare:</strong> 4-6UI EV<br>
                    &nbsp;&nbsp;&nbsp;(0,04-0,06ml Actrapid 100UI/ml)<br>
                    &nbsp;&nbsp;&nbsp;Iniezione EV lenta (1-2min)
                </div>
                <div>
                    <strong>3.</strong> Ricontrollo ogni 15-30min<br>
                    <strong>4.</strong> Rivaluta IVT se glicemia &lt;350<br>
                    &nbsp;&nbsp;&nbsp;e nessun stroke mimic
                </div>
            </div>
        </div>

        <!-- EMERGENZE -->
        <div class="section">
            <div class="section-title urgent">üöë GESTIONE EMERGENZE</div>
            <div style="display: grid; grid-template-columns: 1fr 1fr; gap: 1mm; font-size: 5px;">
                <div>
                    <strong>Angioedema orolinguale:</strong><br>
                    ‚Ä¢ Stop Alteplase + ACE-i<br>
                    ‚Ä¢ <strong>Metilprednisolone</strong> 125mg EV<br>
                    ‚Ä¢ <strong>Clorfeniramina</strong> 10mg EV<br>
                    ‚Ä¢ Se grave: <strong>Adrenalina</strong> 0,3ml SC<br>
                    ‚Ä¢ Alt: <strong>Icatibant</strong> 3ml (30mg) SC<br>
                    <br>
                    <strong>Sindrome riperfusione:</strong><br>
                    ‚Ä¢ Cefalea, crisi, alteraz. coscienza<br>
                    ‚Ä¢ PA target &lt;120/80 (labetalolo)
                </div>
                <div>
                    <strong>Ipotensione:</strong><br>
                    ‚Ä¢ Liquidi EV + vasopressori<br>
                    ‚Ä¢ Se bradicardia: Atropina 0,5mg IV<br>
                    <br>
                    <strong>ICH sintomatica:</strong><br>
                    ‚Ä¢ Stop IVT immediato<br>
                    ‚Ä¢ PCC-4F 25-50 UI/kg<br>
                    ‚Ä¢ Acido tranexamico 1g EV<br>
                    ‚Ä¢ Neurochirurgia urgente<br>
                    <br>
                    <strong>Se NIHSS +4:</strong> Stop IVT + TC urgente
                </div>
            </div>
        </div>
    </div>
</body>
</html>